- Home
- BAND vs BCRX Comparison
BAND vs BCRX Comparison
Compare BAND & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BAND | BCRX |
|---|---|---|
| Founded | 2000 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | 2017 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BAND | BCRX |
|---|---|---|
| Price | $47.76 | $9.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $24.50 | $20.82 |
| AVG Volume (30 Days) | 1.2M | ★ 3.3M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $204,113,000.00 | $25,186,000.00 |
| Revenue This Year | $15.16 | N/A |
| Revenue Next Year | $6.18 | $12.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.26 | N/A |
| 52 Week Low | $12.50 | $6.00 |
| 52 Week High | $79.08 | $11.22 |
Technical Indicators
Market Signals| Indicator | BAND | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.13 | 49.50 |
| Support Level | $14.03 | $8.13 |
| Resistance Level | $77.53 | $9.67 |
| Average True Range (ATR) | 3.61 | 0.51 |
| MACD | 0.59 | 0.02 |
| Stochastic Oscillator | 52.23 | 44.27 |
Price Performance
Historical ComparisonAbout BAND Bandwidth Inc.
Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of its revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.